author-photo

Christopher Kaiser

Eli Lilly and Company

30

Papers

728

Citations

Citation Trend

Filter By

Papers (26) Sort By

Journal Conference Others

Phase 1 study of tabalumab, a human anti-B-cell activating factor antibody, and bortezomib in patients with relapsed/refractory multiple myeloma

2016 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (14)
A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma

2014 Cancer
Show All
- Source
- Cite
- Save
Citations (13)
A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma

2013 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (9)
Phase 1 Study of Tabalumab, a Human Anti-BAFF Antibody and Bortezomib in Patients with Previously-Treated Multiple Myeloma

2012 Blood
Show All
- Source
- Cite
- Save
Citations (11)
Phase II results of tasisulam-sodium in previously treated patients with metastatic breast cancer.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
The 2010 Racial and Gender Report Card: National Basketball Association

2010
Show All
- Source
- Cite
- Save
Citations (6)
A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer

2009 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (46)
Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC)

2009
Show All
- Source
- Cite
- Save
Citations (14)
1BA Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

2007 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
A Randomized Phase II Trial of Pemetrexed plus Irinotecan (ALIRI) versus Leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in First-Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

2007 Oncology
Show All
- Source
- Cite
- Save
Citations (16)